Hyperthyroidism: genes and variants
Explore variant evidence for Hyperthyroidism across 4 analyzed proteins (THRB, TSHR, CTLA4, TPO). Linked ClinVar records include 11 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hyperthyroidism
THRB: Thyroid hormone receptor beta
A nuclear receptor that binds thyroid hormones and regulates hormone-responsive genes. Pathogenic variants can cause resistance to thyroid hormone beta.
10 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in THRB have source records linked to Hyperthyroidism. Association strength is not clinical gene validity.
TSHR: Thyrotropin receptor
TSH signaling through this pathway drives thyroid-hormone synthesis, iodine handling, and thyroid growth. Activating variants can cause autonomous hyperthyroidism, whereas loss-of-function variants can cause TSH resistance and congenital hypothyroidism.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in TSHR have source records linked to Hyperthyroidism. Association strength is not clinical gene validity.
CTLA4: Cytotoxic T-lymphocyte protein 4
It restrains T-cell activation by competing with CD28 for CD80 and CD86 and by delivering inhibitory signals after immune activation. Haploinsufficiency causes immune dysregulation with autoimmunity and lymphoproliferation, while therapeutic blockade enhances antitumor immunity.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CTLA4 have source records linked to Hyperthyroidism. Association strength is not clinical gene validity.
TPO: Thyroid peroxidase
It oxidizes iodide and catalyzes iodination and coupling reactions on thyroglobulin that generate thyroid hormones. Biallelic loss-of-function variants cause thyroid dyshormonogenesis and congenital hypothyroidism, usually with goiter if untreated.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TPO have source records linked to Hyperthyroidism. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): TTR.
Where Hyperthyroidism variants cluster
- THRB NR LBD (positions 217–461): 8 of 8 ClinVar pathogenic / likely pathogenic variants, 1.9× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Hyperthyroidism
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| THRB R320H | 320 | NR LBD | Pathogenic / likely pathogenic (★★★★) |
| THRB A317T | 317 | NR LBD | Pathogenic / likely pathogenic (★★★★) |
| THRB R320L | 320 | NR LBD | Pathogenic / likely pathogenic (★★★★) |
| THRB R429Q | 429 | NR LBD | Pathogenic / likely pathogenic (★★★★) |
| THRB R243W | 243 | NR LBD | Pathogenic / likely pathogenic (★★★★) |
| THRB A234T | 234 | NR LBD | Pathogenic / likely pathogenic (★★★★) |
| THRB A317S | 317 | NR LBD | Pathogenic / likely pathogenic (★★) |
| THRB P453S | 453 | NR LBD | Pathogenic / likely pathogenic (★★) |
| THRB D322N | 322 | NR LBD | Pathogenic / likely pathogenic (★) |
| THRB I431M | 431 | NR LBD | Pathogenic / likely pathogenic (★) |
| TSHR A485V | 485 | Extracellular | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Hyperthyroidism
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 93 out of 100
- MutPred: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 90 out of 100
Same protein, different disease
- Thyroid hormone resistance, generalized, autosomal dominant also has ClinVar records linked to THRB variants; they fall mostly in different places as the Hyperthyroidism variants (35 pathogenic / likely pathogenic).
- Selective pituitary resistance to thyroid hormone also has ClinVar records linked to THRB variants; they fall partly in the same places as the Hyperthyroidism variants (5 pathogenic / likely pathogenic).
- Generalized resistance to thyroid hormone also has ClinVar records linked to THRB variants; they fall partly in the same places as the Hyperthyroidism variants (4 pathogenic / likely pathogenic).
- Hypothyroidism due to TSH receptor mutations also has ClinVar records linked to TSHR variants; they fall mostly in different places as the Hyperthyroidism variants (24 pathogenic / likely pathogenic).
- Familial hyperthyroidism due to mutations in TSH receptor also has ClinVar records linked to TSHR variants; they fall mostly in different places as the Hyperthyroidism variants (18 pathogenic / likely pathogenic).
- Familial gestational hyperthyroidism also has ClinVar records linked to TSHR variants; they fall mostly in different places as the Hyperthyroidism variants (13 pathogenic / likely pathogenic).
- Thyroid adenoma, hyperfunctioning, somatic also has ClinVar records linked to TSHR variants; they fall mostly in different places as the Hyperthyroidism variants (5 pathogenic / likely pathogenic).
- Ovarian cancer also has ClinVar records linked to TSHR variants; they fall mostly in different places as the Hyperthyroidism variants (4 pathogenic / likely pathogenic).
Diseases related to Hyperthyroidism
- Hypothyroidism, also linked to CTLA4, THRB, TPO and TSHR
- Ovarian cancer, also linked to TSHR
- Thyroid hormone resistance, generalized, autosomal dominant, also linked to THRB
- Hypothyroidism due to TSH receptor mutations, also linked to TSHR
- Deficiency of iodide peroxidase, also linked to TPO
- Familial hyperthyroidism due to mutations in TSH receptor, also linked to TSHR
- Non-small cell lung carcinoma, also linked to CTLA4
- Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, also linked to CTLA4
- Inherited Immunodeficiency Diseases, also linked to CTLA4
- Familial gestational hyperthyroidism, also linked to TSHR
- Type 1 diabetes mellitus, also linked to CTLA4
- Hepatocellular carcinoma, also linked to CTLA4
Frequently asked questions
Which genes have records linked to Hyperthyroidism?
This view contains 4 analyzed proteins: THRB, TSHR, CTLA4, TPO. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 11 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 18 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center